Table 3.
U.S. Hispanic and Mexican Women Combined | |||
---|---|---|---|
Cases N=2,703 |
Controls N=3,254 |
||
N | N | OR 95% CIa | |
Parityb by duration of breast-feeding (months)c | |||
1 birth | |||
No breast-feeding | 183 | 124 | 1.0 |
1–12 months breast-feeding | 191 | 168 | 0.74 0.54–1.02 |
≥13 months breast-feeding | 26 | 24 | 0.65 0.35–1.21 |
2–3 births | |||
No breast-feeding | 432 | 436 | 0.72 0.54–0.95 |
1–12 months breast-feeding | 784 | 818 | 0.68 0.52–0.88 |
≥13 months breast-feeding | 246 | 324 | 0.54 0.40–0.73 |
≥4 births | |||
No breast-feeding | 168 | 216 | 0.65 0.47–0.89 |
1–12 months breast-feeding | 307 | 457 | 0.53 0.40–0.72 |
≥13 months breast-feeding | 366 | 687 | 0.49 0.37–0.65 |
P interaction = 0.56 | |||
Age at first live birth (years) by duration of breast-feeding (months)d | |||
<20 years | |||
≥13 months breast-feeding | 245 | 441 | 1.0 |
1–12 months breast-feeding | 327 | 447 | 1.05 0.84–1.32 |
No breast-feeding | 183 | 208 | 1.26 0.96–1.65 |
20–29 years | |||
≥13 months breast-feeding | 326 | 526 | 1.04 0.84–1.30 |
1–12 months breast-feeding | 776 | 854 | 1.26 1.02–1.55 |
No breast-feeding | 470 | 482 | 1.38 1.11–1.74 |
≥30 years | |||
≥13 months breast-feeding | 67 | 68 | 1.23 0.83–1.85 |
1–12 months breast-feeding | 179 | 142 | 1.55 1.14–2.11 |
No breast-feeding | 130 | 86 | 1.88 1.32–2.67 |
P interaction = 0.47 | |||
Abbreviations: 4-CBCS, 4-Corners Breast Cancer Study; HR+, hormone receptor positive (estrogen receptor positive and/or progesterone receptor positive); MBCS, Mexico Breast Cancer Study; NC-BCFR, Northern California Breast Cancer Family Registry; SFBCS, San Francisco Bay Area Breast Cancer Study.
Odds ratios and 95% confidence intervals, adjusted for age (years; continuous), study (SFBCS, NC-BCFR, 4-CBCS,MCBS), education (less than high school, high school graduate, post high school education), family history of breast cancer in first-degree relatives (no, yes), age at menarche (<12, 12, 13, ≥14 years), hormonal contraception use (never, former, current), menopausal status and hormone therapy use (premenopausal, postmenopausal never used HT, postmenopausal past HT use, postmenopausal current HT use, menopausal status unknown), average daily alcohol consumption (0, 0.1–4.9, 5–9.9, ≥10 grams), and body mass index in reference year (<25.0, 25.0–29.9, ≥30.0 kg/m2).
Number of live births.
Adjusted additionally for age at first live birth.
Adjusted additionally for parity